Henry Schein Announces $400 Million Share Repurchase Plan
Henry Schein announced a new share repurchase program authorized by its Board of Directors, allowing the buyback of up to $400 million of common stock. This plan complements a previous $400 million repurchase program from August 2022, expected to conclude by the end of the first quarter of 2023. With approximately 131.5 million shares outstanding, the new authorization accounts for about 3.8% of total shares. The program underscores the company’s confidence in its BOLD +1 Strategic Plan and financial stability, which enables it to invest in growth while enhancing shareholder value.
- New repurchase program of $400 million reflects confidence in the company's strategy.
- Share repurchase could enhance shareholder value and EPS by reducing outstanding shares.
- None.
This program is in addition to the
The Company had approximately 131.5 million shares outstanding as of
“Henry Schein's share repurchase program reflects our confidence in the Company’s 2022-2024 BOLD +1 Strategic Plan for sustainable growth and value creation,” said Ronald N. South, Senior Vice President and Chief Financial Officer of Henry Schein. “We are pleased that our strong balance sheet provides us with the flexibility and financial stability to pursue new markets while strengthening and broadening our comprehensive offering of health care solutions.”
About
Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.
A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in
For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, Instagram.com/HenrySchein, and Twitter.com/HenrySchein.
Cautionary Note Regarding Forward-Looking Statements
In accordance with the “Safe Harbor” provisions of the Private Securities Litigation Reform Act of 1995, we provide the following cautionary remarks regarding important factors that, among others, could cause future results to differ materially from the forward-looking statements, expectations and assumptions expressed or implied herein. All forward-looking statements made by us are subject to risks and uncertainties and are not guarantees of future performance. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance and achievements or industry results to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These statements include EPS guidance and are generally identified by the use of such terms as “may,” “could,” “expect,” “intend,” “believe,” “plan,” “estimate,” “forecast,” “project,” “anticipate,” “to be,” “to make” or other comparable terms. A fuller discussion of our operations, financial condition and status of litigation matters, including factors that may affect our business and future prospects, is contained in documents we have filed with the
Risk factors and uncertainties that could cause actual results to differ materially from current and historical results include, but are not limited to: risks associated with COVID-19 and any variants thereof, as well as other disease outbreaks, epidemics, pandemics, or similar wide-spread public health concerns and other natural disasters; our dependence on third parties for the manufacture and supply of our products; our ability to develop or acquire and maintain and protect new products (particularly technology products) and technologies that achieve market acceptance with acceptable margins; transitional challenges associated with acquisitions, dispositions and joint ventures, including the failure to achieve anticipated synergies/benefits; financial and tax risks associated with acquisitions, dispositions and joint ventures; certain provisions in our governing documents that may discourage third-party acquisitions of us; effects of a highly competitive (including, without limitation, competition from third-party online commerce sites) and consolidating market; the repeal or judicial prohibition on implementation of the Affordable Care Act; changes in the health care industry; risks from expansion of customer purchasing power and multi-tiered costing structures; increases in shipping costs for our products or other service issues with our third-party shippers; general global and domestic macroeconomic and political conditions, including inflation, deflation, recession and fluctuations in energy pricing and the value of the
We caution that these factors may not be exhaustive and that many of these factors are beyond our ability to control or predict. Accordingly, any forward-looking statements contained herein should not be relied upon as a prediction of actual results. We undertake no duty and have no obligation to update forward-looking statements except as required by law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230210005377/en/
Investors
Ronald N. South
Senior Vice President and Chief Financial Officer
ronald.south@henryschein.com
(631) 843-5500
Vice President, Investor Relations
graham.stanley@henryschein.com
(631) 843-5963
Media
Vice President, Global Corporate Media Relations
annmarie.gothard@henryschein.com
(631) 390-8169
Source:
FAQ
What is the significance of Henry Schein's new share repurchase program?
How much of Henry Schein's stock will be repurchased under the new program?
When was the previous repurchase program announced?
How many shares does Henry Schein have outstanding?